Dr. David B. Vasily, MD
Dermatology (Dermatology Physician)
- Medicare participating
At a glance
- Medical school
- State University of New York at Buffalo School of Medicine (1975)
- Years since graduation
- 51
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 2,107
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1975Medical school: State University of New York at Buffalo School of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
PA license MD018025E
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Lehigh Valley Dermatology Assoc, LTD. (5 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 2,107
- Services billed
- 53,555
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 39,000 | 108 |
| Established patient office or other outpatient visit, 20-29 minutes | 1,802 | 1,269 |
| Ultrasonic guidance for placement of radiation therapy fields | 1,621 | 91 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 1,506 | 77 |
| Superficial and/or low voltage radiation treatment delivery | 1,453 | 79 |
| Destruction of precancer skin growth, 2-14 growths | 1,196 | 330 |
| Destruction of precancer skin growth, 1 growth | 706 | 537 |
| Established patient office or other outpatient visit, 10-19 minutes | 531 | 425 |
| Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 490 | 23 |
| Biopsy of related skin growth, first growth | 490 | 425 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 12 companies reported 32 payments worth $707 in total to this clinician.
| Galderma Laboratories, L.P. | $197 |
|---|---|
| AbbVie Inc. | $177 |
| Janssen Biotech, Inc. | $71.07 |
| Revance Therapeutics, Inc. | $63.62 |
| UCB, Inc. | $47.97 |
| Amgen Inc. | $33.55 |
| Mayne Pharma Commercial LLC | $30.26 |
| Paratek Pharmaceuticals, Inc. | $23.82 |
| Food and Beverage | $698 |
|---|---|
| Education | $9.65 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AbbVie Inc. Mar 7, 2025 | Education SKYRIZI · IMMUNOLOGY · in-kind | $9.65 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.